All In MedTech

Device Trial Radar · NCT06896734

mobiCARE™ ECG Monitoring System

Evaluation of the mobiCARE™ ECG Monitoring System Electrode Placement Positioning Limits in a Prospective, Non-Randomized, Single-Center U.S. Study

Last checked: Nov 20, 2026Latest source record: May 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

49

Actual

Start

Jan 1, 2025

Primary completion

Feb 5, 2025

Study completion Mar 16, 2025

Sponsor

Lead sponsor
Seers Technology Co., Ltd.Not on our public-company list
Sponsor type
Industry
Collaborators
Eminence Clinical Research, Inc.
First posted
Mar 26, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Evaluation of the mobiCARE™ ECG Monitoring System Electrode Placement Positioning Limits in a Prospective, Non-Randomized, Single-Center U.S. Study

Conditions

  • ECG Monitoring

Interventions

  • Evaluation of the ECG signal in the nominal location and in three alternate positionsDevice

    Evaluation of the ECG signal in the nominal location and in three alternate positions to determine if the three alternate positions are interpretable.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Subjects in Which the ECG Signal is Interpretable at the Nominal Location and up to 3 Alternate PositionsTime frame: 2 minutes while the patient ambulates

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • MCB Clinical Research Centers, LLC

    Colorado Springs, Colorado

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.